329 related articles for article (PubMed ID: 16270346)
1. In vitro enzymatic stability of dendritic peptides.
Yang H; Lopina ST
J Biomed Mater Res A; 2006 Feb; 76(2):398-407. PubMed ID: 16270346
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of thermoresponsive polyamidoamine-polyethylene glycol-poly(D,L-lactide) core-shell nanoparticles.
Kailasan A; Yuan Q; Yang H
Acta Biomater; 2010 Mar; 6(3):1131-9. PubMed ID: 19716444
[TBL] [Abstract][Full Text] [Related]
3. Stealth dendrimers for antiarrhythmic quinidine delivery.
Yang H; Lopina ST
J Mater Sci Mater Med; 2007 Oct; 18(10):2061-5. PubMed ID: 17558476
[TBL] [Abstract][Full Text] [Related]
4. Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: synthesis, characterization, and evaluation of cytotoxicity.
Kim Y; Klutz AM; Jacobson KA
Bioconjug Chem; 2008 Aug; 19(8):1660-72. PubMed ID: 18610944
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid.
Madaan K; Lather V; Pandita D
Drug Deliv; 2016; 23(1):254-62. PubMed ID: 24845475
[TBL] [Abstract][Full Text] [Related]
6. Stealth dendrimers for drug delivery: correlation between PEGylation, cytocompatibility, and drug payload.
Yang H; Lopina ST; DiPersio LP; Schmidt SP
J Mater Sci Mater Med; 2008 May; 19(5):1991-7. PubMed ID: 17952565
[TBL] [Abstract][Full Text] [Related]
7. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
Ke W; Shao K; Huang R; Han L; Liu Y; Li J; Kuang Y; Ye L; Lou J; Jiang C
Biomaterials; 2009 Dec; 30(36):6976-85. PubMed ID: 19765819
[TBL] [Abstract][Full Text] [Related]
8. Association of the anti-tuberculosis drug rifampicin with a PAMAM dendrimer.
Bellini RG; GuimarĂ£es AP; Pacheco MA; Dias DM; Furtado VR; de Alencastro RB; Horta BA
J Mol Graph Model; 2015 Jul; 60():34-42. PubMed ID: 26093506
[TBL] [Abstract][Full Text] [Related]
9. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
10. Octa-arginine modified poly(amidoamine) dendrimers for improved delivery and cytotoxic effect of paclitaxel in cancer.
Rompicharla SVK; Kumari P; Ghosh B; Biswas S
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):847-859. PubMed ID: 29790795
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of pegylated dendrimeric nanocarrier for pulmonary delivery of low molecular weight heparin.
Bai S; Ahsan F
Pharm Res; 2009 Mar; 26(3):539-48. PubMed ID: 19034631
[TBL] [Abstract][Full Text] [Related]
12. PEGylated thermo-sensitive poly(amidoamine) dendritic drug delivery systems.
Zhao Y; Fan X; Liu D; Wang Z
Int J Pharm; 2011 May; 409(1-2):229-36. PubMed ID: 21316434
[TBL] [Abstract][Full Text] [Related]
13. Modulated cellular delivery of anti-VEGF siRNA (bevasiranib) by incorporating supramolecular assemblies of hydrophobically modified polyamidoamine dendrimer in stealth liposomes.
Golkar N; Samani SM; Tamaddon AM
Int J Pharm; 2016 Aug; 510(1):30-41. PubMed ID: 27291973
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.
Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y
Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851
[TBL] [Abstract][Full Text] [Related]
15. PAMAM dendrimers for the delivery of the antibacterial Triclosan.
Gardiner J; Freeman S; Leach M; Green A; Alcock J; D'Emanuele A
J Enzyme Inhib Med Chem; 2008 Oct; 23(5):623-8. PubMed ID: 18821252
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of photocurable polyamidoamine dendrimer hydrogels as a versatile platform for tissue engineering and drug delivery.
Desai PN; Yuan Q; Yang H
Biomacromolecules; 2010 Mar; 11(3):666-73. PubMed ID: 20108892
[TBL] [Abstract][Full Text] [Related]
17. Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice.
Singh P; Gupta U; Asthana A; Jain NK
Bioconjug Chem; 2008 Nov; 19(11):2239-52. PubMed ID: 18950215
[TBL] [Abstract][Full Text] [Related]
18. Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
Huang RQ; Qu YH; Ke WL; Zhu JH; Pei YY; Jiang C
FASEB J; 2007 Apr; 21(4):1117-25. PubMed ID: 17218540
[TBL] [Abstract][Full Text] [Related]
19. Chondrocyte affinity peptide modified PAMAM conjugate as a nanoplatform for targeting and retention in cartilage.
Hu Q; Chen Q; Yan X; Ding B; Chen D; Cheng L
Nanomedicine (Lond); 2018 Apr; 13(7):749-767. PubMed ID: 29528264
[TBL] [Abstract][Full Text] [Related]
20. PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma.
Jiang Y; Lv L; Shi H; Hua Y; Lv W; Wang X; Xin H; Xu Q
Colloids Surf B Biointerfaces; 2016 Nov; 147():242-249. PubMed ID: 27518456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]